"Mesothelioma is a hideous disease that is inevitably fatal." Lord Philiip's opening words in Sienkiewicz v Grief (UK) Ltd remain sadly true, yet there is some cause for cautious optimism that new drugs are capable of significantly extending life expectancy while maintaining a high quality of life.
In the latest episode of the Kings Chambers Debrief Podcast, Nigel Poole QC, Michael Rawlinson QC and Jeremy Roussak discuss the various mechanisms by which defendants (and their insurers) can be induced and, if necessary, forced to fund treatment for mesothelioma.
The podcast is available here and can be streamed on iTunes and Spotify.
For more information regarding our podcast series or to request a copy of the factsheet for Episode 7 "Mesothelioma and Immunotherapy" please contact us via firstname.lastname@example.org
Section 21A applications and interim declarations: The implications of DP v Hillingdon
NEW DATE: Five Things You Need to Know About P and Their Property
© Copyright 2020 Kings Chambers. All rights reserved.
Continue using site